Quantitative Electrocorticographic Biomarkers of Clinical Outcomes in Mesial Temporal Lobe Epileptic Patients Treated With the RNS System Desai N, Tchen T, Morrell MJ. Clinical Neurophysiology. 2019;130:1364-1374. doi:10.1016/j.clinph.2019.05.017. OBJECTIVES: Find interictal electrocorticographic (ECoG) biomarkers of clinical outcomes in mesiotemporal lobe (MTL) epilepsy patients. METHODS: In the NeuroPace RNS System clinical trials with 256 patients, 20 MTL patients with the most reduction in clinical seizures at year 7 compared to baseline (upper response quartile: 96.5% median change) and 20 with the least reduction in clinical seizures (lower response quartile: 17.4% median change) were evaluated. Clinical and interictal ECoG features from the 2 response quartiles were compared. RESULTS: Demographic and clinical features were similar in the upper and lower response quartiles. Interictal spike rate (ISR) was substantially lower (P 25 Hz) were also different (P
CITATION STYLE
King-Stephens, D. (2020). Do Interictal Rates Influence Treatment Outcomes in Temporal Lobe Epilepsy? Epilepsy Currents, 20(2), 83–84. https://doi.org/10.1177/1535759720903025
Mendeley helps you to discover research relevant for your work.